Category Ranking

98%

Total Visits

921

Avg Visit Duration

2 minutes

Citations

20

Article Abstract

Many children in Head Start programs do not meet physical activity (PA) and dietary intake recommendations and have increased risk for obesity. The purpose of this pilot study was to formatively assess a multi-level intervention, exploring strategies to encourage PA and healthy eating among north Texas Head Start families. In year 1, 5 Head Start sites with 217 children began the Head Start to Healthy Lifestyles (HSHL) project. Direct and indirect education strategies began in the last 2 months of the school year. Surveys were used to evaluate child and caregiver PA, healthy eating behaviors, and interagency collaboration. Strategies and barriers to adopting healthy lifestyles were assessed via grant partner discussions. Of 217 children enrolled, 109 caregivers consented to participate in research, of which 35 completed baseline surveys and 10 also submitted post surveys. The number of fruits eaten by Head Start caregivers improved ( < .05). Perceived level of collaboration among grant partners was high. Strategies appreciated by Head Start site partners included PA support in the classrooms, take-home gardens, and reading food group books. Additional needed support included tasting and on-site cooking classes. Barriers to participation included few face-to-face meetings with parents, staffing shortages post-COVID, and difficulty engaging families.

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC11583171PMC
http://dx.doi.org/10.1177/15598276231221512DOI Listing

Publication Analysis

Top Keywords

head start
28
healthy eating
12
physical activity
8
start caregivers
8
217 children
8
healthy lifestyles
8
head
7
start
7
healthy
5
promising practices
4

Similar Publications

A multicenter retrospective analysis of recurrent/metastatic nasopharyngeal cancer from non-endemic areas: Results in the pre-immunotherapy era.

Eur J Cancer

September 2025

Medical Oncology and Hematology Unit, IRCCS Humanitas Research Hospital, Rozzano, Milan, Italy; Department of Biomedical Sciences, Humanitas University, Milan, Italy.

Aim Of The Study: The aim of the study is to describe clinical features, treatment approach and outcomes of recurrent/metastatic (R/M) NPC in non-endemic areas MATERIALS AND METHODS: This observational, retrospective and multicenter study was conducted within 36 referral hospital in non-endemic areas including Europe, Jordan, Kuwait, Turkey and United States of America. All NPC patients diagnosed between 2004 and 2016 and with a minimum 12 months of follow-up were included. Data entry started in January 2018 and closed in December 2023.

View Article and Find Full Text PDF

This study used a qualitative research design to investigate the key components, infrastructure, processes, and facilitators involved in the implementation of Pathways Home Early Childhood, a housing support pilot program implemented within a Head Start grantee for families facing homelessness, as well as how participating parents experienced the program. We held parent interviews, a staff focus group, and stakeholder interviews with a total of 22 informants, followed by thematic analysis and a member-checking group. Findings include salient guidance for similar efforts to screen for homelessness and provide support and navigation to families.

View Article and Find Full Text PDF

Background: Radiation therapy is a common treatment for head and neck (H&N) cancers. Radiomic features, which are determined from biomedical imaging, can be effective biomarkers used to assess tumor heterogeneity and have been used to predict response to treatment. However, most studies employ only a single biomedical imaging modality to determine radiomic features.

View Article and Find Full Text PDF

Background: All three cyclin-dependent kinase 4/6 inhibitors (CDK4/6i; palbociclib, ribociclib, and abemaciclib) plus aromatase inhibitor (AI) significantly prolonged progression-free survival (PFS) versus placebo plus AI and achieved a similar reduction in risk of disease progression in randomized controlled trials (RCTs) evaluating first-line (1L) treatment of hormone receptor (HR)-positive/human epidermal growth factor receptor 2 (HER2)-negative metastatic breast cancer (mBC). To date, there have been no head-to-head RCT data comparing CDK4/6i, and most real-world comparative effectiveness studies were limited by small sample sizes and/or short follow-up. In this analysis, we compared real-world PFS (rwPFS) in patients with HR-positive/HER2-negative mBC receiving 1L CDK4/6i plus AI in United States routine clinical practice.

View Article and Find Full Text PDF

Dupilumab, a monoclonal antibody targeting interleukin-4 (IL-4) and IL-13, is widely used for the treatment of type 2 inflammatory conditions such as atopic dermatitis, asthma, and chronic rhinosinusitis with nasal polyposis. Although generally well-tolerated, dupilumab has been linked to rare thyroid-related events. We report a case of Graves' disease (GD) in a 47-year-old man with severe nasal polyposis who developed heat intolerance and weight loss within six to eight weeks of starting dupilumab.

View Article and Find Full Text PDF